Literature DB >> 6297229

Hirano bodies in myelinated fibers of hepatic encephalopathy.

K Okamoto, S Hirai, A Hirano.   

Abstract

Inclusions, essentially identical to Hirano bodies, were observed in the substantia nigra, dentate nuclei, and frontal lobes in three autopsy cases of hepatic encephalopathy. Similar inclusions were not observed in these areas in nine controls. The inclusions were mainly seen in the inner loops of the myelinated fibers, between the myelin lamellae, and among degenerated myelin sheaths. The same inclusions were rarely observed in postsynaptic terminals.

Entities:  

Mesh:

Year:  1982        PMID: 6297229     DOI: 10.1007/bf00688615

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Fine structural changes in the mutant hamster with hind leg paralysis.

Authors:  A Hirano
Journal:  Acta Neuropathol       Date:  1977-08-31       Impact factor: 17.088

2.  Light and electron microscopic observations on the relationship between Hirano bodies, neuron and glial perikarya in the human hippocampus.

Authors:  P H Gibson
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

3.  Ultrastructure of Hirano bodies.

Authors:  S S Schochet; W F McCormick
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

4.  A study of rod-like structures (Hirano bodies) in 240 normal and pathological brains.

Authors:  J Ogata; G N Budzilovich; H Cravioto
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

5.  Fine structure of the Pick and Hirano bodies in a case of Pick's disease.

Authors:  S S Schochet; P W Lampert; R Lindenberg
Journal:  Acta Neuropathol       Date:  1968-11-01       Impact factor: 17.088

6.  Fibrillary accumulations in oligodendrogial processes of rats subjected to protocaval anastomosis.

Authors:  J B Cavanagh; W F Blakemore; M H Kyu
Journal:  J Neurol Sci       Date:  1971-10       Impact factor: 3.181

Review 7.  The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration.

Authors:  M Victor; R D Adams; M Cole
Journal:  Medicine (Baltimore)       Date:  1965-09       Impact factor: 1.889

8.  Some effects of vinblastine implantation in the cerebral white matter.

Authors:  A Hirano; H M Zimmerman
Journal:  Lab Invest       Date:  1970-10       Impact factor: 5.662

9.  Oligodendroglial changes induced by intrathecal vincristine sulfate.

Authors:  S S Schochet; P W Lampert; K M Earle
Journal:  Exp Neurol       Date:  1969-01       Impact factor: 5.330

10.  Intraneuronal conglomerates in sporadic motor neuron disease. A light and electron microscopic study.

Authors:  S S Schochet; J M Hardman; P P Ladewig; K M Earle
Journal:  Arch Neurol       Date:  1969-05
View more
  6 in total

1.  The structure analysis of Hirano bodies by digital processing on electron micrographs.

Authors:  H Mori; M Tomonaga; N Baba; K Kanaya
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Hirano body in extraocular muscle.

Authors:  M Tomonaga
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

3.  Hirano bodies in the perikaryon of the Purkinje cell in a case of Alzheimer's disease.

Authors:  T Yamamoto; A Hirano
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

4.  Hirano body in an inflammatory cell of leptomeningeal vessel infected by fungus Paecilomyces.

Authors:  K L Ho; P A Allevato
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

5.  Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis.

Authors:  Sangdeuk Ha; Ruth Furukawa; Marcus Fechheimer
Journal:  Neurobiol Aging       Date:  2010-02-04       Impact factor: 4.673

6.  Hirano body expression impairs spatial working memory in a novel mouse model.

Authors:  Matthew Furgerson; Jason K Clark; Jonathon D Crystal; John J Wagner; Marcus Fechheimer; Ruth Furukawa
Journal:  Acta Neuropathol Commun       Date:  2014-09-02       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.